There is evidence that c-myc is expressed in renal carcinomas and that
it is associated with histological grade. This study reports on the c
linical correlations of oncogene expression and clinical features of t
he disease. Tissue sections from 97 patients (95 primary and 12 second
ary cancers) were immunostained with a c-myc oncoprotein antibody. The
tumours were scored for extent and intensity of nuclear and cytoplasm
ic staining. Ninety patients were suitable for follow-up study. High l
evels of expression correlated significantly with increasing T categor
y and nuclear grade, as well as with venous invasion. No correlation w
ith nodal involvement, the presence of metastases, tumour architecture
or cell type was found. The extent of nuclear staining was related to
survival (although not to recurrence), but in a multivariate analysis
did not provide independent prognostic information. It was concluded
that semiquantitative assessment of levels of c-myc oncoprotein does n
ot provide clinically useful prognostic information.